Bioequivalence Trial Conducted for Two Insulin Degludec/Liraglutide (IDegLira) Formulations in Healthy Subjects
A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
Abstract
A trial assessed the expected biological equivalence between two formulations of Insulin Degludec/Liraglutide (IDegLira) with identical active ingredients in healthy volunteers.